FIELD: medicine.
SUBSTANCE: native amniotic membrane is placed into a storage solution containing BSS, gentamicin sulphate, amphotericin B, riboflavin. The amniotic membrane is placed into a sterile container and exposed to ultraviolet light; the ultraviolet exposure is combined with riboflavin instillations. The treated amniotic membrane is placed into the solution containing BSS, gentamicin sulphate, amphotericin B.
EFFECT: increasing the mechanical strength and biological properties of the amniotic membrane for the purpose of increasing the keratoplasty efficacy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PROCESSING HUMAN CADAVERIC KERATODERMA PRECEDING KERATOPLASTY | 2008 |
|
RU2381649C1 |
| METHOD OF TREATING ENDOTHELIAL-EPITHELIAL DYSTROPHY OF THE EYE CORNEA | 2017 |
|
RU2647480C1 |
| METHOD FOR AMNIOTIC MEMBRANE DISSECTION FOR INTRASTROMAL IMPLANTATION INTO CORNEAL STROMA ON ICE-COLD SURFACE | 2012 |
|
RU2519357C2 |
| METHOD OF CORNEAL GRAFT PREPARATION FOR LAYER-BY-LAYER KERATOPLASTY | 2019 |
|
RU2723135C1 |
| PRESERVING AGENT FOR DONOR CORNEA | 2010 |
|
RU2450515C1 |
| KERATECTASIAS TREATMENT METHOD | 2017 |
|
RU2645931C1 |
| METHOD OF TREATING EPITHELIAL-ENDOTHELIAL CORNEAL DYSTROPHY | 2019 |
|
RU2703361C1 |
| MEANS FOR PRESERVATION OF THE POSTERIOR LAYER TRANSPLANT OF THE DONOR CORNEA | 2018 |
|
RU2676311C1 |
| MEDIUM FOR EYE CORNEA CONSERVATION | 1993 |
|
RU2069951C1 |
| INTRASTROMAL KERATOPLASTY FOR KERATOCONUS | 2021 |
|
RU2773801C1 |
